arcus biosciences stock news

Get the latest Arcus Biosciences Inc RCUS real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. RCUS delivered earnings and revenue surprises of 42832 and.

Arcus Biosciences Inc Shares Close The Week 20 6 Higher Weekly Wrap Nasdaq

Whats Happening With Arcus Biosciences Inc Stock Today.

. The low in the last 52 weeks of Arcus Biosciences stock was 1675. So based on the above formula the ROE for Arcus Biosciences is. HAYWARD Calif October 25 2022--Arcus Biosciences Inc.

Arcus Biosciences Inc. In other Arcus Biosciences news COO Jennifer Jarrett sold 12677 shares of Arcus Biosciences stock in a transaction that occurred on Friday September 16th. Arcus Biosciences Inc.

Their RCUS share price forecasts range from 3600 to 6000. What was the 52. Arcus Biosciences RCUS Gets a Buy from Berenberg Bank.

2 days agoIn other Arcus Biosciences news COO Jennifer Jarrett sold 12677 shares of Arcus Biosciences stock in a transaction on Friday September. News information and stories for ARCUS BIOSCIENCES INC. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

Get Arcus Biosciences Inc RCUSNYSE real-time stock quotes news price and financial information from CNBC. The stock was sold at an. The return is the amount.

NYSERCUS an oncology-focused biopharmaceutical company working to create best-in-class cancer. Arcus Biosciences Inc. NYSERCUS an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies today.

Arcus Biosciences Inc RCUS stock is trading at 2613 as of 238 PM on Monday Oct 31 a loss of -176 or -631. A high-level overview of Arcus Biosciences Inc. According to the current price Arcus Biosciences is 16567 away from the 52-week low.

In other Arcus Biosciences news COO Jennifer Jarrett sold 12677 shares of the stock in a transaction that occurred on Friday September 16th. NYSERCUS an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies today announced that the. The parties will co-develop Gilead-optioned programs globally and will co-commercialize in the US with Gilead commercializing outside of the US subject to the rights of Arcuss existing.

RCUS Q4 Earnings and Revenues Surpass Estimates. RCUS stock at Seeking Alpha. 72 US57m US797m Based on the trailing twelve months to March 2022.

10252022 0506pm EDT. Arcus Biosciences started at overweight with 40 stock price target at Morgan Stanley. On average they anticipate the.

Get the latest news and real-time alerts from Arcus Biosciences Inc. NYSERCUS traded at 2775 at close of the session on Friday 102822 made a downward move of -355 on its previous days price. 8 brokers have issued 1 year price targets for Arcus Biosciences shares.

Arcus Biosciences NYSERCUS Stock Price Down 68. The shares were sold at an.

Arcus Biosciences Inc Rcus Stock Price Quote News Stock Analysis